Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study-Reference-Cited by-同舟云学术

Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study

Published:2013-04-23 Issue:5 Volume:65 Page:718-728
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Nash Peter,Nayiager Sauithree,Genovese Mark C.,Kivitz Alan J.,Oelke Kurt,Ludivico Charles,Palmer William,Rodriguez Cristian,Delaet Ingrid,Elegbe Ayanbola,Corbo Michael

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Rheumatology

Reference36 articles.

1. Immunogenicity of therapeutic proteins;Schellekens;Nephrol Dial Transplant,2003

2. Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis;Haggerty;J Rheumatol,2007

3. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up;Bartelds;JAMA,2011

4. Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors;Anderson;Curr Rheumatol Rep,2005

5. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis;Maini;Arthritis Rheum,1998

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis;Scientific Reports;2023-09-14

2. Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study;Clinical Therapeutics;2023-09

3. Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases;Journal of Clinical Medicine;2023-05-04

4. Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study;Modern Rheumatology;2022-04-07

5. Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis;Rheumatology Advances in Practice;2022